Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

DiaMedica Reports $11.3 Million Third-Quarter Net Loss as ReMEDy2 Tops 200 Enrollments

None

DiaMedica Therapeutics (DMAC) reported a third-quarter 2026 net loss of $11.3 million, or $0.21 per basic and diluted share, compared with a net loss of $8.6 million, or $0.17 per share, a year earlier. The clinical-stage biopharmaceutical company ended September with $34.9 million in cash, cash equivalents and short-term investments.

The company completed enrollment in the first two cohorts of its Phase 2 early-onset fetal growth restriction trial and said its ReMEDy2 Phase 2/3 acute ischemic stroke trial surpassed 200 participants, enabling a planned interim analysis after the 200th participant completes 90-day follow-up.

  • Research and development expense was $9.2 million in the quarter, compared with $6.4 million a year earlier.
  • General and administrative expense was $2.4 million, versus $2.6 million in the prior-year quarter.
  • DiaMedica expects its current cash, cash equivalents and short-term investments to fund planned clinical studies and operations into the fourth quarter of 2027.
  • A virtual KOL event featuring preliminary results from the first two FGR cohorts is scheduled for November 24, 2026.
  • The ReMEDy2 interim analysis is expected to be completed in the first quarter of 2027.
EARLY ACCESS
Receive DMAC Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$DMAC Hedge Fund Activity

We have seen 49 institutional investors add shares of $DMAC stock to their portfolio, and 37 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles